Tolerability of different first-line treatment (trt) regimens in patients (pts) with advanced or metastatic renal cell carcinoma (mRCC).

31. Mai 2010

Müller, L., Münch, A., Blumenstengel, K., Hutzschenreuther, U., Busies, S., 2010.

J Clin Oncol 28(Sup. abstr e15086). doi: 10.1200/jco.2010.28.15_suppl.e15086